GDC-8264

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GDC-8264, covering 2025-04-24 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE) [Phase 2]

See pricing